MedTrace Logo

Preemptive Analgesia With Amitryptyline for Prevention of Pain in Women After Hysterectomy

NCT03587025 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-11-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether amitryptyline is effective in the prevention of pain in women after a total abdominal hysterectomy.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Amitriptyline

Amitriptyline compared with placebo for preemptive analgesia in women after abdominal hysterectomy.

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • University of Campinas, Brazil

    lead OTHER

Principal Investigators

  • Guilherme V Mascena, PhD · FCM-CG

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2018-10-30
Completion
2018-10-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587025 on ClinicalTrials.gov